Elsevier

Environmental Research

Volume 193, February 2021, 110491
Environmental Research

Serum levels of non-persistent environmental pollutants and risk of incident hypertension in a sub-cohort from the EPIC study

https://doi.org/10.1016/j.envres.2020.110491Get rights and content

Highlights

  • Concentrations of 7 npEPs were quantified in serum from 670 adults.

  • Detection rates ranged from 19.6% (BP) to 88.5% (MP).

  • PP concentrations were positively associated with AHT risk.

  • No associations were found for the rest of pollutants.

Abstract

Background

The prevalence of arterial hypertension (AHT), a well-known risk factor for cardiovascular disease, has considerably increased over last decades. Non-persistent environmental pollutants (npEPs) are a group of ubiquitous chemicals, widely used in consumer products such as food packaging and cosmetics, which have been identified as endocrine disrupting chemicals and obesogens. The aim of this study was to assess the potential associations of serum levels of three groups of npEPs with the risk of incident AHT.

Methods

Cohort study within a sub-cohort of Granada EPIC-Spain center (n = 670). We quantified serum concentrations of three groups of npEPs, i.e., bisphenol A (BPA), four parabens: methylparaben (MP), ethylparaben (EP), propylparaben (PP) and butylparaben (BP), and two benzophenones: benzophenone 1 (BP1), benzophenone 3 (BP3), in samples collected at recruitment. Statistical analyses were performed by means of Cox Proportional Hazard Models.

Results

Median follow-up time was 23 years. BPA and MP were found in >80% of the study population. Individuals within the 4th PP quartile (0.53–9.24 ng/ml) showed a statistically significant increased risk of AHT (HR = 1.40, p = 0.015). No associations were found for the rest of pollutants.

Conclusions

Overall, we evidenced no associations of most npEPs with AHT risk, with the exception of an increased risk in the highest PP percentiles. Considering the limitations of using one spot serum sample for exposure characterization, further research on the potential contribution of npEPs on the development of AHT risk is warranted.

Introduction

The global prevalence of Arterial hypertension (AHT) has markedly increased over last decades, reaching 40% of adults >25 years old in 2010 (Mills et al., 2016; WHO, 2013). The worldwide age-standardized prevalence of raised blood pressure (systolic blood pressure [SBP] ≥140 mm Hg or diastolic blood pressure [DBP] ≥90 mm Hg) in adults was estimated as ≥ 20% in 2015 (Stanaway et al., 2018; Zhou et al., 2017). In addition, SBP >115 mm Hg has been considered as the leading risk factor for the global burden of disease in 2017 (Stanaway et al., 2018).

External and potentially-modifiable risk factors affecting the development of AHT include unhealthy diet (e.g. high salt intake), lack of physical activity, obesity, smoking, and exposure to persistent stress (WHO, 2013). Among environmental aspects, the role of chronic exposure to low doses of ubiquitous environmental pollutants is of increasing concern (Ahmadkhaniha et al., 2014; Amin et al., 2019; Duan et al., 2018; Gong et al., 2013; Grice et al., 2017; Hwang et al., 2018; Ngwa et al., 2015; Provvisiero et al., 2016; Ruzzin et al., 2010; Silver et al., 2011; Yang et al., 2017). Specifically, there is a group of widely-used chemicals, known as non-persistent environmental pollutants (npEPs) (Artacho-Cordón et al., 2018). Among them, Bisphenol A (BPA) is an industrial chemical originally developed as a synthetic oestrogen, widely used in the manufacture of polymers and epoxy resins, as well as in polycarbonate and polysulfone plastics. BPA is one of the highest volume chemicals produced worldwide (Mcgroup, 2013) and, consequently, the general population is frequently and inadvertently exposed to this chemical (Geens et al., 2012; vom Saal and Hughes, 2005). In this regard, it has been estimated that >90% of the general population in the US, Europe and Asia present detectable values of BPA (Hormann et al., 2014; Liao and Kannan, 2012; Vandenberg et al, 2009, 2010). Diet is considered the main exposure route to BPA in the general population, since it is frequently present in food packaging, e.g., tins, cans, or plastic boxing, from which BPA can migrate to the food under certain environmental conditions (Brotons et al., 1995; Ćwiek-Ludwicka, 2015; Geens et al., 2012; Grumetto et al., 2008; Hahladakis et al., 2018; Huang et al., 2017; López-Cervantes and Paseiro-Losada, 2003).

On the other hand, parabens (PBs) are widely used as antimicrobial preservatives in cosmetics, pharmaceuticals, food and beverages (Cosmetic Ingredient Review, 2008) and Benzophenones (BPs) are synthetic chemicals frequently used in personal care products UV filters (Louis et al., 2014). BPs have been detected in urine and some other biological matrices, such as placenta (Vela-Soria et al., 2011), human breast milk (Schlumpf et al., 2008) and menstrual blood (Jiménez-Díaz et al., 2016).

In general, npEPs are rapidly eliminated from humans. Indeed, BPA is readily glucuro-conjugated or sulfo-conjugated in the liver, and finally excreted in urine, once absorbed in the intestine (half-life in humans: 7–8 h) (vom Saal and Hughes, 2005). In the same way, PBs and BPs are also rapidly metabolized and excreted from the body, mainly during the first 24 h after exposure (Błędzka et al., 2014; Soni et al., 2005; Watanabe et al., 2015).

These npEPs are considered potential metabolic and endocrine disruptors, since they can induce metabolic syndrome–related conditions (Casals-Casas and Desvergne, 2011; Heindel et al., 2015). In this regard, these pollutants can act as obesogens, which are functionally defined as chemicals that promote obesity and, thus, obesity-related diseases, including insulin resistance, cardiovascular disease or even cancer (Hwang et al., 2018; Shankar and Teppala, 2012; Trasande et al., 2012) in humans or animals (Grü;n and Blumberg, 2006). Suspected biological mechanisms include thyroid dysfunction (Streeten et al., 1988), weight gain (Juhaeri et al., 2002), insulin resistance (Sowers, 2004), hyperlipidaemia (Laaksonen et al., 2008), oxidative stress (Rodrigo et al., 2007), and higher systemic inflammation (Lakoski et al., 2006). However, the implications of npEP exposure and AHT to the general population are still controversial due to the lack of homogeneous results (Bae et al., 2012; Bae and Hong, 2015; Gao and Wang, 2014; Shankar et al., 2012; Shankar and Teppala, 2012; Shiue, 2014a, 2014b).

The present study, which is framed within the European Prospective Investigation into Cancer and Nutrition (EPIC) study, aims to assess longitudinal associations of serum concentrations of selected npEPs at recruitment with the risk of incident AHT.

Section snippets

Study design and study population: The EPIC cohort

This research is designed as a longitudinal study within a sub-cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC), recruited in Granada, Spain. Information at baseline and data collection were explained elsewhere (Riboli et al., 2003). Approval for our study was obtained from the ethical review boards of the International Agency for Research on Cancer and from the Granada EPIC center.

Recruitment in Granada was described elsewhere (Salamanca-Fernández et al., 2020

Results

The average age of the participants in our study population, was 53.0 years (range 35.2–67.6), and 52.1% were women. At baseline, 58.7% of participants were considered to be moderately active, 46.5% of them had overweight and 60.7% had never smoked (Table 1). During the study period (Median follow-up time = 22.8 years), there were 482 (71.9%) incident AHT diagnoses in our sub-cohort (Table 1).

Table 2 depicts a description of npEP serum levels. BPA and MP were found in 83.8% and 83.5% of the

Discussion

Our results suggested an increased risk of incident AHT in those individuals with the highest PP serum concentrations at recruitment. However, we found no evident associations with the rest pollutants (BPA, MP, EP, BP, BP1 and BP3) (Fig. 1). Our results are in consonance with previous findings in EPIC-Granada subcohort of an increased risk of Type-2 Diabetes Mellitus in those individuals with the highest serum PP concentrations (Salamanca-Fernández et al., 2020). Moreover, our study population

Conclusions

Overall, we evidenced no associations of most npEPs with AHT risk, with the exception of an increased risk in the highest PP percentiles. In view of the high prevalence of the exposure as well as the epidemic burden of the disease in current society, we consider that our results are relevant and contribute to the scientific knowledge in the area. Further research on the potential contribution of npEPs on the development of AHT risk is warranted.

Funding sources

This research was supported in part by research grants from the Instituto de Salud Carlos III (PI14/00067). The authors are grateful to Instituto de Salud Carlos III (Miguel Servet Type I Program CP15/00193) for the research contract. Dr. J.P. Arrebola is under contract within Ramon y Cajal program (RYC-2016-20155, Ministerio de Economía, Industria y Competitividad, Spain) and Dr. N. Olea is the recipient of Contrato para la intensificación de la actividad investigadora en el Sistema Nacional

Ethics statement

All participants were informed at recruitment and they signed an informed consent. This study was approved by Ethics Committee of Granada (Comité de Ética de la Investigación Biomédica de Granada).

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work would not have been possible without the generous collaboration of the EPIC participants. This paper will be part of the doctoral thesis developed by Elena Salamanca-Fernández in the context of the “Programa de Doctorado en Medicina Clínica y Salud Pública.

References (103)

  • I. Jiménez-Díaz et al.

    Determination of personal care products -benzophenones and parabens- in human menstrual blood

    J. Chromatogr. B Anal. Technol. Biomed. Life Sci.

    (2016)
  • S. Kang et al.

    Urinary paraben concentrations among pregnant women and their matching newborn infants of Korea, and the association with oxidative stress biomarkers

    Sci. Total Environ.

    (2013)
  • V. Lenters et al.

    Early-life exposure to persistent organic pollutants (OCPs, PBDEs, PCBs, PFASs) and attention-deficit/hyperactivity disorder: a multi-pollutant analysis of a Norwegian birth cohort. Environ

    Bar Int.

    (2019)
  • J.A. Martínez et al.

    Epigenetics in adipose tissue, obesity, weight loss, and diabetes

    Adv. Nutr

    (2014)
  • M.A. Martínez et al.

    Comparing dietary and non-dietary source contribution of BPA and DEHP to prenatal exposure: a Catalonia (Spain) case study

    Environ. Res.

    (2018)
  • M.E. Mendelsohn

    Protective effects of estrogen on the cardiovascular system

    Am. J. Cardiol.

    (2002)
  • P. Mirmira et al.

    Bisphenol A, obesity, and type 2 diabetes mellitus: genuine concern or unnecessary preoccupation?

    Transl. Res.

    (2014)
  • K. Nowak et al.

    Parabens and their effects on the endocrine system

    Mol. Cell. Endocrinol.

    (2018)
  • P. Phrakonkham et al.

    Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis

    J. Steroid Biochem. Mol. Biol.

    (2008)
  • R. Rezg et al.

    Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives

    Environ. Int.

    (2014)
  • M.G. Soni et al.

    Safety assessment of esters of p-hydroxybenzoic acid (parabens)

    Food Chem. Toxicol.

    (2005)
  • F. Vela-Soria et al.

    A multiclass method for the analysis of endocrine disrupting chemicals in human urine samples. Sample treatment by dispersive liquid–liquid microextraction

    Talanta

    (2014)
  • F. Vela-Soria et al.

    Determination of benzophenones in human placental tissue samples by liquid chromatography-tandem mass spectrometry

    Talanta

    (2011)
  • Y. Watanabe et al.

    Metabolism of UV-filter benzophenone-3 by rat and human liver microsomes and its effect on endocrine-disrupting activity

    Toxicol. Appl. Pharmacol.

    (2015)
  • Ezz H.S. Aboul et al.

    The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino rats

    Cytotechnology

    (2013)
  • R. Ahmadkhaniha et al.

    Association of urinary bisphenol a concentration with type-2 diabetes mellitus

    J. Environ. Heal. Sci. Eng

    (2014)
  • P. Alonso-Magdalena et al.

    The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ

    Health Perspect.

    (2006)
  • M.M. Amin et al.

    Association of exposure to Bisphenol A with obesity and cardiometabolic risk factors in children and adolescents

    Int. J. Environ. Health Res.

    (2019)
  • S. Bae et al.

    Exposure to bisphenol A from drinking canned beverages increases blood pressure

    Hypertension

    (2015)
  • S. Bae et al.

    Associations of bisphenol a exposure with heart rate variability and blood pressure

    Hypertension

    (2012)
  • J.A. Brotons et al.

    Xenoestrogens released from lacquer coatings in food cans

    Environ. Health Perspect.

    (1995)
  • A.M. Calafat et al.

    Misuse of blood serum to assess exposure to bisphenol A and phthalates

    Breast Cancer Res.

    (2013)
  • C. Casals-Casas et al.

    Endocr. Disruptors: From Endocrine to Metabolic Disruption. Annu. Rev. Physiol

    (2011)
  • Cosmetic Ingredient Review

    Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products

    Int. J. Toxicol.

    (2008)
  • K. Ćwiek-Ludwicka

    Bisphenol A (BPA) in food contact materials - new scientific opinion from EFSA regarding public health risk

    Rocz. Państwowego Zakładu Hig

    (2015)
  • X. Gao et al.

    Impact of bisphenol A on the cardiovascular system — epidemiological and experimental evidence and molecular mechanisms

    Int. J. Environ. Res. Publ. Health

    (2014)
  • H. Gong et al.

    Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes

    PloS One

    (2013)
  • B.A. Grice et al.

    Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality

    Occup. Environ. Med.

    (2017)
  • L. Grumetto et al.

    Determination of bisphenol A and bisphenol B residues in canned peeled tomatoes by reversed-phase liquid chromatography

    J. Agric. Food Chem.

    (2008)
  • F. Grun et al.

    Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling

    Endocrinology

    (2006)
  • J.J. Heindel et al.

    Environmental obesogens: mechanisms and controversies. Annu. Rev. Pharmacol

    Toxicol

    (2019)
  • J.J. Heindel et al.

    Parma consensus statement on metabolic disruptors

    Environ. Heal

    (2015)
  • H. Hiroi et al.

    Differential interactions of bisphenol A and 17β-estradiol with estrogen receptor α (ERα) and ERβ

    Endocr. J.

    (1999)
  • A.M. Hormann et al.

    Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA)

    PloS One

    (2014)
  • S. Hwang et al.

    Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis. BMC Endocr

    Disord

    (2018)
  • Iman M Mourad Yasser Khadrawy

    The Sensetivity of Liver, Kidney and Testis of Rats to Oxidative Stress Induced by Different Doses of Bisphenol A | Request PDF

    (2012)
  • L. Jian et al.

    Kinetic evaluation of the ciliotoxicity of methyl- and propyl-p-hydroxybenzoates using factorial experiments

    J. Pharm. Pharmacol.

    (1993)
  • Stevens J. Juhaeri et al.

    Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study

    Int. J. Obes.

    (2002)
  • L. Kolatorova et al.

    Parabens and their relation to obesity. Physiol. Res

    (2018)
  • D.E. Laaksonen et al.

    Dyslipidaemia as a predictor of hypertension in middle-aged men

    Eur. Heart J.

    (2008)
  • Cited by (7)

    • Paraben exposures and their interactions with ESR1/2 genetic polymorphisms on hypertension

      2022, Environmental Research
      Citation Excerpt :

      Later, Warembourg and his colleagues observed inverse associations between second-trimester urinary paraben concentrations and diastolic blood pressure (DBP) levels in pregnant women (e.g., DBP decreased by 0.62 mm Hg for every doubling of methylparaben concentrations) (Warembourg et al., 2019). More recently, Salamanca-Fernández et al. reported that subjects in the fourth quartile of PrP had a 1.40-fold increased risk of arterial hypertension, compared with the first quartile group (Salamanca-Fernández et al., 2021). These inconsistent findings remain to be solved.

    • Nanosafety vs. nanotoxicology: adequate animal models for testing in vivo toxicity of nanoparticles

      2021, Toxicology
      Citation Excerpt :

      They showed the ability of pollutants to change the course of acute and chronic diseases indirectly caused by the contaminants (Attademo et al., 2017; Bashir et al., 2020; Bragg-Gresham et al., 2018; Calderon-Garciduenas et al., 2020; Conticini et al., 2020; Fattorini and Regoli, 2020; Stanifer et al., 2016; To et al., 2015; Travaglio et al., 2021). Great importance is connected with the role of chronic exposure to low doses of ubiquitous environmental pollutants (Salamanca-Fernández et al., 2021). The urgent problem is that nanomaterials are not only independent new pollutants, but their widespread use is planned to eliminate the toxic effects of classical pollutants (Alharbi et al., 2020; Poon et al., 2019; Zhao et al., 2019).

    View all citing articles on Scopus
    1

    These authors equally contributed to this work.

    View full text